By favoring opioid medications as the cheaper option when compared with safer but more expensive alternatives, insurers may have helped enlarge the opioid crisis.
That’s according to a report by the New York Times and independent journalism organization ProPublica, which says that the New York State attorney general’s office may be taking a closer look at the role insurers and pharmacy benefit managers might be playing in the crisis. Last week the AG’s office sent letters to the three largest pharmacy benefit managers, CVS Caremark, Express Scripts and OptumRx, asking how they were addressing the crisis.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Marlene Satter
Marlene Y. Satter has worked in and written about the financial industry for decades.
